Ep 196 - CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

DeviceTalks Weekly

Jun 21 2024 | 00:48:11

00:00 / 00:48:11

Episode 196 • June 21, 2024 • 00:48:11

Hosted By

Show Notes

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a...

Play

01:13:17

Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X...

Play

00:48:15

Ep 158 - CEO Meelby Jensen on holding Ambu’s top spot in single-use scopes; Also, Why is Wall Street cranky?

A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw...

Play

00:49:33

Show Notes

Other Episodes

Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

Ep 158 - CEO Meelby Jensen on holding Ambu’s top spot in single-use scopes; Also, Why is Wall Street cranky?